Cargando…
Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease
OBJECTIVES: There is an increasing need to identify reliable biomarkers for distinguishing Crohn’s disease (CD) from other gastrointestinal disorders sharing similar clinical and pathological features. This study aimed at evaluating the diagnostic potential of antibodies to zymogen granule glycoprot...
Autores principales: | Zhang, Shulan, Luo, Jing, Wu, Ziyan, Roggenbuck, Dirk, Schierack, Peter, Reinhold, Dirk, Li, Ji, Zeng, Xiaofeng, Zhang, Fengchun, Qian, Jiaming, Li, Yongzhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830545/ https://www.ncbi.nlm.nih.gov/pubmed/29446764 http://dx.doi.org/10.1038/ctg.2018.1 |
Ejemplares similares
-
Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serologic Biomarkers in Chinese Patients With Crohn Disease
por: Zhang, Shulan, et al.
Publicado: (2015) -
Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome
por: Zhang, Shulan, et al.
Publicado: (2015) -
Association between MEFV Mutations M694V and M680I and Behçet’s Disease: A Meta-Analysis
por: Wu, Ziyan, et al.
Publicado: (2015) -
Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome
por: Zhang, Shulan, et al.
Publicado: (2016) -
Next-Generation Autoantibody Testing by Combination of Screening and Confirmation—the CytoBead® Technology
por: Sowa, Mandy, et al.
Publicado: (2016)